Tech Company M&A Transactions
Elevation Pharmaceuticals Acquisition
Based in San Diego, Elevation Pharmaceuticals was acquired by Sunovion Pharmaceuticals. Sunovion Pharmaceuticals disclosed that the acquisition price was $430 million.
Transaction Overview
Company Name
Acquired By
Announced On
8/31/2012
Transaction Type
M&A
Amount
$430,000,000
M&A Terms
According to the terms of the agreement, Sunovion will make an upfront payment of US$100 million to the shareholders of Elevation on closing of the acquisition of its shares, and thereafter it will make development milestone payments for EP-101 up to US$90 million. Furthermore, after the regulatory approval, Sunovion will also make commercial milestone payments up to US$210 million. Subsequent milestone payments up to $30 million could occur contingent upon the successive development of additional new programs.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11455 El Camino Real 460
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Founded in 2008, Elevation Pharmaceuticals is developing a pipeline of improved aerosol drug products for COPD patients. Our founding team has a successful track record starting companies and building dedicated teams to develop new drug products that improve patients' lives.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 8/31/2012: Wallaby Financial venture capital transaction
Next: 8/31/2012: Predilytics venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs